ProPhase Labs, Inc. (PRPH) bonds
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
ProPhase Labs reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2015
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in ProPhase Labs's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| 2024 Collateralized Loan Agreement | 6.00% | – | $500.00K |
| 2024 Future Receipts Financing | – | $3.00M | – |
| 2024 Second Future Receipts Financing | – | $1.90M | – |
| 2024 Term Note | 15.00% | $500.00K | – |
| 2024 Third Future Receipts Financing | – | $675.00K | $169.00K |
| 2025 Collateralized Loan Agreement | 6.00% | – | $900.00K |
| Amended Second Future Receipts Financing Agreement | – | $2.10M | $1.10M |
| Amended Third Future Receipts Financing Agreement | – | – | $514.00K |
| August2025 Future Receipts Financing Agreements | – | $1.40M | $1.30M |
| CEO Loan | 10.00% | $625.00K | – |
| First Twenty Twenty Six Future Receipts Financing Agreement | – | $116.00K | – |
| JXVII Note | – | $10.00M | – |
| January Labrys Note Convertible | 10.00% | $180.00K | – |
| March Labrys Note Convertible | 10.00% | $78.00K | – |
| Note Convertible | 10.00% | $240.00K | – |
| PMI Note | 15.00% | $1.00M | – |
| Second Amended Slate Financing Agreement | – | – | $722.00K |
| Second Twenty Twenty Six Future Receipts Financing Agreement | – | $289.00K | – |
| September2025 Future Receipts Financing Agreements | – | $75.00K | $158.00K |
| Third Amended Slate Financing Agreement | – | – | $1.50M |
| Third August2025 Note Convertible at $65 a share | – | $238.00K | – |
| Third Twenty Twenty Six Future Receipts Financing Agreement | – | $90.00K | – |
| Twenty Twenty Five Collateralized Loan Agreement | 6.00% | – | $900.00K |
| Twenty Twenty Four Collateralized Loan Agreement | 6.00% | – | $500.00K |
| Two Thousand Twenty Six Short Term Loans Convertible | – | $187.50K | – |
| Unaffiliated Investor Loan | 10.00% | $625.00K | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?